Ibogaine microdosing in a patient with bipolar depression: a case report

Ibogaine microdosing in a patient with bipolar depression: a case report

Bibliographic Details
Main Authors:	Maria Helha Fernandes-Nascimento, Karine Viana-Ferreira, Bruno Daniel Rasmussen Chaves, André Brooking Negrão, Yuan-Pang Wang
Format:	Article
Language:	English
Published:	Associação Brasileira de Psiquiatria (ABP) 2022-07-01
Series:	Brazilian Journal of Psychiatry
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462022005007205&tlng=en

Similar Items

N-(Hydroxymethyl)ibogaine
by: Mohamed Damak, et al.
Published: (2008-09-01)

The therapeutic potential of microdosing psychedelics in depression
by: Kim P.C. Kuypers
Published: (2020-08-01)

Cardiac arrest after ibogaine intoxication
by: Christian Steinberg, et al.
Published: (2018-08-01)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
by: Joseph M. Rootman, et al.
Published: (2021-11-01)

Effects of ibogaine per os treatment on redox homeostasis in rat kidney
by: Vidonja-Uzelac Teodora, et al.
Published: (2019-01-01)

Managing expectations with psychedelic microdosing
by: Omer A. Syed, et al.
Published: (2023-11-01)

Asking questions of psychedelic microdosing
by: Lindsay P Cameron
Published: (2021-03-01)

Microdosing: Concept, application and relevance
by: Tushar Tewari, et al.
Published: (2010-01-01)

Cheaper Than A Funeral: Considering Ibogaine’s Psychedelic Journey and Therapeutic Potential
by: Daly, Noah
Published: (2024)

Effects of ibogaine per os application on redox homeostasis in rat liver and erythrocytes
by: Vidonja-Uzelac Teodora, et al.
Published: (2019-01-01)

A systematic study of microdosing psychedelics.
by: Vince Polito, et al.
Published: (2019-01-01)

Psychedelic microdosing benefits and challenges: an empirical codebook
by: Thomas Anderson, et al.
Published: (2019-07-01)

Ibogaine Blocks Cue- and Drug-Induced Reinstatement of Conditioned Place Preference to Ethanol in Male Mice
by: Gabrielle M. Henriques, et al.
Published: (2021-09-01)

IUPHAR – invited review - Ibogaine – A legacy within the current renaissance of psychedelic therapy
by: Deborah C. Mash
Published: (2023-04-01)

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
by: Joseph M. Rootman, et al.
Published: (2022-06-01)

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
by: Soledad Marton, et al.
Published: (2019-03-01)

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis
by: David Qixiang Chen, et al.
Published: (2025-02-01)

Microdosing psychedelics in the treatment of ADHD and comorbid disorders
by: K. P. Kuypers
Published: (2024-04-01)

Ibogaine (iboga tabernanthe) as a potential anti-addictive treatment in the pipeline : a short communication
by: Mohamed Nazar, Nor Ilyani
Published: (2014)

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
by: Joseph M. Rootman, et al.
Published: (2022-07-01)

LSD increases sleep duration the night after microdosing
by: Nathan Allen, et al.
Published: (2024-04-01)

Self-blinding citizen science to explore psychedelic microdosing
by: Balázs Szigeti, et al.
Published: (2021-03-01)

Determinants of millet and sorghum yield with fertilizer microdosing technique
by: Penda SISSOKO, et al.
Published: (2019-06-01)

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes
by: Deborah C. Mash, et al.
Published: (2018-06-01)

Framework for Microdosing Odors in Virtual Reality for Psychophysiological Stress Training
by: Daniel Anheuer, et al.
Published: (2024-10-01)

Case report: Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion
by: Jonathan E. Dickinson, et al.
Published: (2023-09-01)

A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets
by: Judit Biosca-Brull, et al.
Published: (2024-01-01)

Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers
by: Gaylord, Shonda T., et al.
Published: (2015)

Keeping the promise: a critique of the current state of microdosing research
by: Rotem Petranker, et al.
Published: (2024-02-01)

Repeated microdoses of LSD do not alter anxiety or boldness in zebrafish
by: Ethan V. Hagen, et al.
Published: (2024-02-01)

Microdosing of Compost for Sustainable Production of Improved Sorghum in Southern Mali
by: Moumini Guindo, et al.
Published: (2022-06-01)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
by: Rebecca S. Ryan, et al.
Published: (2023-03-01)

Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin
by: Doris Hexsel, et al.
Published: (2023-07-01)

Microbial population dynamics under microdoses of the essential oil arborvitae
by: Rhegan C. McGregor, et al.
Published: (2019-09-01)

Correctness of use of microdosed combination oral contraceptives in young women
by: N A Buralkina
Published: (2017-08-01)

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
by: Pasquale LR, et al.
Published: (2018-11-01)

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
by: Ana Carolina Ruver-Martins, et al.
Published: (2022-07-01)

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
by: Carina Joy Donegan, et al.
Published: (2023-10-01)

Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile
by: Joaquín González, et al.
Published: (2018-04-01)

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
by: Jennifer Rozylo, et al.
Published: (2020-01-01)